24th EHA Annual Meeting Published June 14, 2019 IMG 5715 « ‹ 1 of 4 › » Recent news» Horizon2020 CARAMBA Myeloma Pipeline information sheet now available in five languages» The FDA approves the first anti-BCMA CAR-T Cell Therapy for myeloma, idecabtagene vicleucel (Abecma)
